Literature DB >> 19417090

In silico mutagenesis: a case study of the melanocortin 4 receptor.

Yana Bromberg1, John Overton, Christian Vaisse, Rudolph L Leibel, Burkhard Rost.   

Abstract

The melanocortin 4 receptor (MC4R) is a G-protein-coupled receptor (GPCR) and a key molecule in the regulation of energy homeostasis. At least 159 substitutions in the coding region of human MC4R (hMC4R) have been described experimentally; over 80 of those occur naturally, and many have been implicated in obesity. However, assessment of the presumably functionally essential residues remains incomplete. Here we have performed a complete in silico mutagenesis analysis to assess the functional essentiality of all possible nonnative point mutants in the entire hMC4R protein (332 residues). We applied SNAP, which is a method for quantifying functional consequences of single amino acid (AA) substitutions, to calculate the effects of all possible substitutions at each position in the hMC4R AA sequence. We compiled a mutability score that reflects the degree to which a particular residue is likely to be functionally important. We performed the same experiment for a paralogue human melanocortin receptor (hMC1R) and a mouse orthologue (mMC4R) in order to compare computational evaluations of highly related sequences. Three results are most salient: 1) our predictions largely agree with the available experimental annotations; 2) this analysis identified several AAs that are likely to be functionally critical, but have not yet been studied experimentally; and 3) the differential analysis of the receptors implicates a number of residues as specifically important to MC4Rs vs. other GPCRs, such as hMC1R.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19417090      PMCID: PMC2735358          DOI: 10.1096/fj.08-127530

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  57 in total

Review 1.  Agouti and agouti-related protein: analogies and contrasts.

Authors:  D M Dinulescu; R D Cone
Journal:  J Biol Chem       Date:  2000-03-10       Impact factor: 5.157

2.  PHAT: a transmembrane-specific substitution matrix. Predicted hydrophobic and transmembrane.

Authors:  P C Ng; J G Henikoff; S Henikoff
Journal:  Bioinformatics       Date:  2000-09       Impact factor: 6.937

Review 3.  Comparative protein structure modeling of genes and genomes.

Authors:  M A Martí-Renom; A C Stuart; A Fiser; R Sánchez; F Melo; A Sali
Journal:  Annu Rev Biophys Biomol Struct       Date:  2000

4.  Structure activity studies of the melanocortin-4 receptor by in vitro mutagenesis: identification of agouti-related protein (AGRP), melanocortin agonist and synthetic peptide antagonist interaction determinants.

Authors:  C Haskell-Luevano; R D Cone; E K Monck; Y P Wan
Journal:  Biochemistry       Date:  2001-05-22       Impact factor: 3.162

5.  The SWISS-PROT protein knowledgebase and its supplement TrEMBL in 2003.

Authors:  Brigitte Boeckmann; Amos Bairoch; Rolf Apweiler; Marie-Claude Blatter; Anne Estreicher; Elisabeth Gasteiger; Maria J Martin; Karine Michoud; Claire O'Donovan; Isabelle Phan; Sandrine Pilbout; Michel Schneider
Journal:  Nucleic Acids Res       Date:  2003-01-01       Impact factor: 16.971

6.  Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein.

Authors:  M M Ollmann; B D Wilson; Y K Yang; J A Kerns; Y Chen; I Gantz; G S Barsh
Journal:  Science       Date:  1997-10-03       Impact factor: 47.728

7.  Cysteine residues are involved in structure and function of melanocortin 1 receptor: Substitution of a cysteine residue in transmembrane segment two converts an agonist to antagonist.

Authors:  P A Frändberg; M Doufexis; S Kapas; V Chhajlani
Journal:  Biochem Biophys Res Commun       Date:  2001-03-09       Impact factor: 3.575

8.  Molecular determinants of melanocortin 4 receptor ligand binding and MC4/MC3 receptor selectivity.

Authors:  Sarah A Nickolls; Mary I Cismowski; Xiaochuan Wang; Meira Wolff; Paul J Conlon; Richard A Maki
Journal:  J Pharmacol Exp Ther       Date:  2003-03       Impact factor: 4.030

9.  Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene.

Authors:  I Sadaf Farooqi; Julia M Keogh; Giles S H Yeo; Emma J Lank; Tim Cheetham; Stephen O'Rahilly
Journal:  N Engl J Med       Date:  2003-03-20       Impact factor: 91.245

10.  Expression of melanocortin 4 receptor mRNA in the central nervous system of the rat.

Authors:  Toshiro Kishi; Carl J Aschkenasi; Charlotte E Lee; Kathleen G Mountjoy; Clifford B Saper; Joel K Elmquist
Journal:  J Comp Neurol       Date:  2003-03-10       Impact factor: 3.215

View more
  20 in total

1.  Mechanism of N-terminal modulation of activity at the melanocortin-4 receptor GPCR.

Authors:  Baran A Ersoy; Leonardo Pardo; Sumei Zhang; Darren A Thompson; Glenn Millhauser; Cedric Govaerts; Christian Vaisse
Journal:  Nat Chem Biol       Date:  2012-06-24       Impact factor: 15.040

2.  Assessment of methods for predicting the effects of PTEN and TPMT protein variants.

Authors:  Vikas Pejaver; Giulia Babbi; Rita Casadio; Lukas Folkman; Panagiotis Katsonis; Kunal Kundu; Olivier Lichtarge; Pier Luigi Martelli; Maximilian Miller; John Moult; Lipika R Pal; Castrense Savojardo; Yizhou Yin; Yaoqi Zhou; Predrag Radivojac; Yana Bromberg
Journal:  Hum Mutat       Date:  2019-07-03       Impact factor: 4.878

3.  Functional Analysis of Single Nucleotide Polymorphism in ZUFSP Protein and Implication in Pathogenesis.

Authors:  Mary B Ajadi; Opeyemi S Soremekun; Adeniyi T Adewumi; Hezekiel M Kumalo; Mahmoud E S Soliman
Journal:  Protein J       Date:  2021-01-29       Impact factor: 2.371

4.  Pharmacological effect of human melanocortin-2 receptor accessory protein 2 variants on hypothalamic melanocortin receptors.

Authors:  Jinye Liang; Lei Li; Xuanxuan Jin; Bingxin Xu; Linyu Pi; Shangyun Liu; Wei Zhu; Cong Zhang; Bing Luan; Lulu Gong; Chao Zhang
Journal:  Endocrine       Date:  2018-04-27       Impact factor: 3.633

5.  Pharmacological characterization of 30 human melanocortin-4 receptor polymorphisms with the endogenous proopiomelanocortin-derived agonists, synthetic agonists, and the endogenous agouti-related protein antagonist.

Authors:  Zhimin Xiang; Bettina Proneth; Marvin L Dirain; Sally A Litherland; Carrie Haskell-Luevano
Journal:  Biochemistry       Date:  2010-06-08       Impact factor: 3.162

6.  The melanocortin-4 receptor: physiology, pharmacology, and pathophysiology.

Authors:  Ya-Xiong Tao
Journal:  Endocr Rev       Date:  2010-02-26       Impact factor: 19.871

7.  Disease-related mutations predicted to impact protein function.

Authors:  Christian Schaefer; Yana Bromberg; Dominik Achten; Burkhard Rost
Journal:  BMC Genomics       Date:  2012-06-18       Impact factor: 3.969

8.  Benchmarking infrastructure for mutation text mining.

Authors:  Artjom Klein; Alexandre Riazanov; Matthew M Hindle; Christopher Jo Baker
Journal:  J Biomed Semantics       Date:  2014-02-25

9.  PredictProtein--an open resource for online prediction of protein structural and functional features.

Authors:  Guy Yachdav; Edda Kloppmann; Laszlo Kajan; Maximilian Hecht; Tatyana Goldberg; Tobias Hamp; Peter Hönigschmid; Andrea Schafferhans; Manfred Roos; Michael Bernhofer; Lothar Richter; Haim Ashkenazy; Marco Punta; Avner Schlessinger; Yana Bromberg; Reinhard Schneider; Gerrit Vriend; Chris Sander; Nir Ben-Tal; Burkhard Rost
Journal:  Nucleic Acids Res       Date:  2014-05-05       Impact factor: 16.971

10.  Evidence of trem2 variant associated with triple risk of Alzheimer's disease.

Authors:  Zainularifeen Abduljaleel; Faisal A Al-Allaf; Wajahatullah Khan; Mohammad Athar; Naiyer Shahzad; Mohiuddin M Taher; Mohamed Elrobh; Mohammed S Alanazi; Waseem El-Huneidi
Journal:  PLoS One       Date:  2014-03-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.